B. Braun - Sharing Expertise

IV Containers

Environmental Safety

  • The incineration of PVC products produces toxic HCl and contributes to acid rain
  • Fewer emissions - 30 times less toxic than PVC when incinerated
  • EXCEL® IV containers weigh 28%- 48% less than comparable PVC containers (both with overwrap)
  • Reduced waste saves 30% annually in landfill and disposal costs

Patient Safety

PVC-free, DEHP-free products help protect susceptible populations: critically ill male neonates, pregnant and lactating women, pediatric patients, adolescent boys, and chemotherapy patients. Animal toxicity studies indicate that the following organs are targeted: testes, liver and kidneys. Medications, such as Taxol, exacerbate DEHP leaching.

Products that exacerbate leaching:

  • Blood/blood products
  • Cyclosporine
  • Chlordiazepoxide HCl
  • Dosetaxel
  • Etoposide
  • Lipid Emulsions
  • Paclitaxel1
  • Teniposide

Sorption risk from the presence of PVC can result in reduced levels of medication being delivered.
The following drugs adsorb to PVC medical products:2,3

  • Aldesleukin
  • Calcitriol
  • Carmustine
  • Chlordiazepoxide HCl
  • Diazepam
  • Insulin
  • Isosorbide Dinitrate
  • Lorazepam
  • Miconazole
  • Nitroglycerin
  • Sufentanil Citrate
  • Thiopental Sodium
  • Urokinase
  • Warfarin Sodium

1 Bristol-Myers Squibb Company, Oncology Division. Taxol (Paclitaxel) Injection Administration, Equipment, 11/99 Equipment
2 Chemical and Physical Compatibility of Selected Drugs in EXCEL® Container System
3 Glass and Accumed™ IV Delivery Systems Drug Additive and Chemical Physical Compatibility Guide